✦ LIBER ✦

Mutations of Fas (APO-1/CD95) and p53 Genes in Nonmelanoma Skin Cancer

✍ Scribed by Laura Boldrini; Barbara Loggini; Silvia Gisfredi; Ylenia Zucconi; Fulvia Baldinotti; Antonella Fogli; Paolo Simi; Gregorio Cervadoro; Paolo Barachini; Fulvio Basolo; Raffaele Pingitore; Gabriella Fontanini

Book ID: 106297937
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 259 KB
Volume: 7
Category: Article
ISSN: 1203-4754
DOI: 10.1007/s10227-002-0105-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alterations of Fas (APO-1/CD 95) gene an

Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer

✍ Boldrini, Laura; Faviana, Pinuccia; Pistolesi, Francesca; Gisfredi, Silvia; Quir 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 222 KB

Somatic mutations in the death domain of

Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer

✍ Won Sang Park; Ro Ra Oh; Young Sil Kim; Jik Young Park; Sug Hyung Lee; Min Sun S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 2 views

It is now believed that genes regulating apoptosis are also important variables in cancer development. Fas, a transmembrane protein of the tumour necrosis factor receptor family, is a key molecule for cell death signalling. The mutation of the primary structure of the Fas gene might also be one of t

Mutant p53 gain of function: repression

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants

✍ Zalcenstein, Amir; Stambolsky, Perry; Weisz, Lilach; Müller, Martina; Wallach, D 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 336 KB

Death pathway genes Fas (Apo-1/CD95) and

Death pathway genes Fas (Apo-1/CD95) and Bik (Nbk) show no mutations in colorectal carcinomas

✍ Abdel-Rahman, W M; Arends, M J; Morris, R G; Ramadan, M E; Wyllie, A H 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Expression of FAS (CD95/APO-1) and FAS l

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance

✍ Reet Koomägi; Manfred Volm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 124 KB 👁 2 views

FIGURE 1 -Immunoblot analyses identify 40 kDa (Fas) and 45 kDa (FasL) proteins.

Expression of Fas (APO-1/CD95) and Fas l

Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma

✍ Gross, N. ;Balmas, K. ;Brognara, C. Beretta ;Tschopp, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views